|
Additional information: b5, d10, h4, h6 (update codes), h11.B5: this was observed during infusion with an unspecified chemotherapy drug.H4: the lot was manufactured february 25-26, 2025.H11: a batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
|